1h Free Analyst Time
The publisher has been monitoring the helicobacter pylori diagnostics market and it is poised to grow by $ 247.67 mn during 2021-2025, progressing at a CAGR of 7.76% during the forecast period. Their report on the helicobacter pylori diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing cost-effectiveness of diagnosis in conjunction with personalized antibiotic therapy and rising prevalence of diseases. In addition, the growing cost-effectiveness of diagnosis in conjunction with personalized antibiotic therapy is anticipated to boost the growth of the market as well.
The helicobacter pylori diagnostics market analysis includes the technology segment and geographic landscape.
The publisher's helicobacter pylori diagnostics market is segmented as below:
By Technology
- Immunoassays
- Molecular diagnostics
- POC
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
Their report on the helicobacter pylori diagnostics market covers the following areas:
- Helicobacter pylori diagnostics market sizing
- Helicobacter pylori diagnostics market forecast
- Helicobacter pylori diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
Table of Contents
Executive Summary- Market overview
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Technology
- Immunoassays - Market size and forecast 2020-2025
- Molecular diagnostics - Market size and forecast 2020-2025
- POC - Market size and forecast 2020-2025
- Market opportunity by Technology
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
- Overview
- Vendor landscape
- Landscape disruption
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Becton Dickinson and Co.
- bioMerieux SA
- Bio Rad Laboratories Inc.
- Cardinal Health Inc.
- F. Hoffmann-La Roche Ltd.
- Omega Diagnostics Group Plc
- QIAGEN NV
- Quest Diagnostics Inc.
- Thermo Fisher Scientific Inc.
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Technology - Market share 2020-2025 (%)
22: Comparison by Technology
23: Immunoassays - Market size and forecast 2020-2025 ($ million)
24: Immunoassays - Year-over-year growth 2020-2025 (%)
25: Molecular diagnostics - Market size and forecast 2020-2025 ($ million)
26: Molecular diagnostics - Year-over-year growth 2020-2025 (%)
27: POC - Market size and forecast 2020-2025 ($ million)
28: POC - Year-over-year growth 2020-2025 (%)
29: Market opportunity by Technology
30: Customer landscape
31: Market share By Geographical Landscape 2020-2025 (%)
32: Geographic comparison
33: North America - Market size and forecast 2020-2025 ($ million)
34: North America - Year-over-year growth 2020-2025 (%)
35: Europe - Market size and forecast 2020-2025 ($ million)
36: Europe - Year-over-year growth 2020-2025 (%)
37: Asia - Market size and forecast 2020-2025 ($ million)
38: Asia - Year-over-year growth 2020-2025 (%)
39: ROW - Market size and forecast 2020-2025 ($ million)
40: ROW - Year-over-year growth 2020-2025 (%)
41: Key leading countries
42: Market opportunity By Geographical Landscape ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: Abbott Laboratories - Overview
50: Abbott Laboratories - Business segments
51: Abbott Laboratories - Key offerings
52: Abbott Laboratories - Key customers
53: Abbott Laboratories - Segment focus
54: Becton Dickinson and Co. - Overview
55: Becton Dickinson and Co. - Business segments
56: Becton Dickinson and Co. - Key offerings
57: Becton Dickinson and Co. - Key customers
58: Becton Dickinson and Co. - Segment focus
59: bioMerieux SA - Overview
60: bioMerieux SA - Business segments
61: bioMerieux SA - Key offerings
62: bioMerieux SA - Key customers
63: bioMerieux SA - Segment focus
64: Bio Rad Laboratories Inc. - Overview
65: Bio Rad Laboratories Inc. - Business segments
66: Bio Rad Laboratories Inc. - Key offerings
67: Bio Rad Laboratories Inc. - Key customers
68: Bio Rad Laboratories Inc. - Segment focus
69: Cardinal Health Inc. - Overview
70: Cardinal Health Inc. - Business segments
71: Cardinal Health Inc. - Key offerings
72: Cardinal Health Inc. - Key customers
73: Cardinal Health Inc. - Segment focus
74: F. Hoffmann-La Roche Ltd. - Overview
75: F. Hoffmann-La Roche Ltd. - Business segments
76: F. Hoffmann-La Roche Ltd. - Key offerings
77: F. Hoffmann-La Roche Ltd. - Key customers
78: F. Hoffmann-La Roche Ltd. - Segment focus
79: Omega Diagnostics Group Plc - Overview
80: Omega Diagnostics Group Plc - Business segments
81: Omega Diagnostics Group Plc - Key offerings
82: Omega Diagnostics Group Plc - Key customers
83: Omega Diagnostics Group Plc - Segment focus
84: QIAGEN NV - Overview
85: QIAGEN NV - Business segments
86: QIAGEN NV - Key offerings
87: QIAGEN NV - Key customers
88: QIAGEN NV - Segment focus
89: Quest Diagnostics Inc. - Overview
90: Quest Diagnostics Inc. - Business segments
91: Quest Diagnostics Inc. - Key offerings
92: Quest Diagnostics Inc. - Key customers
93: Quest Diagnostics Inc. - Segment focus
94: Thermo Fisher Scientific Inc. - Overview
95: Thermo Fisher Scientific Inc. - Business segments
96: Thermo Fisher Scientific Inc. - Key offerings
97: Thermo Fisher Scientific Inc. - Key customers
98: Thermo Fisher Scientific Inc. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton Dickinson and Co.
- bioMerieux SA
- Bio Rad Laboratories Inc.
- Cardinal Health Inc.
- F. Hoffmann-La Roche Ltd.
- Omega Diagnostics Group Plc
- QIAGEN NV
- Quest Diagnostics Inc.
- Thermo Fisher Scientific Inc.
